vs
Side-by-side financial comparison of Dole plc (DOLE) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Dole plc is the larger business by last-quarter revenue ($2.3B vs $1.5B, roughly 1.5× BeOne Medicines Ltd.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 0.2%, a 4.2% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 10.5%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $66.5M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 3.2%).
Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
DOLE vs ONC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.3B | $1.5B |
| Net Profit | $5.1M | $66.5M |
| Gross Margin | 6.8% | 90.5% |
| Operating Margin | 1.1% | 12.4% |
| Net Margin | 0.2% | 4.4% |
| Revenue YoY | 10.5% | 32.8% |
| Net Profit YoY | -64.6% | 143.8% |
| EPS (diluted) | $0.05 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.5B | ||
| Q3 25 | $2.3B | $1.4B | ||
| Q2 25 | $2.4B | $1.3B | ||
| Q1 25 | $2.1B | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $2.1B | $1.0B | ||
| Q2 24 | $2.1B | $929.2M | ||
| Q1 24 | $2.1B | $751.7M |
| Q4 25 | — | $66.5M | ||
| Q3 25 | $5.1M | $124.8M | ||
| Q2 25 | $10.0M | $94.3M | ||
| Q1 25 | $38.9M | $1.3M | ||
| Q4 24 | — | $-151.9M | ||
| Q3 24 | $14.4M | $-121.3M | ||
| Q2 24 | $80.1M | $-120.4M | ||
| Q1 24 | $70.1M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | 6.8% | 86.1% | ||
| Q2 25 | 9.0% | 87.5% | ||
| Q1 25 | 8.7% | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | 8.0% | 83.0% | ||
| Q2 24 | 9.4% | 85.1% | ||
| Q1 24 | 9.2% | 83.4% |
| Q4 25 | — | 12.4% | ||
| Q3 25 | 1.1% | 11.5% | ||
| Q2 25 | 4.3% | 6.7% | ||
| Q1 25 | 3.2% | 1.0% | ||
| Q4 24 | — | -7.0% | ||
| Q3 24 | 2.3% | -12.0% | ||
| Q2 24 | 4.0% | -11.5% | ||
| Q1 24 | 5.3% | -34.8% |
| Q4 25 | — | 4.4% | ||
| Q3 25 | 0.2% | 8.8% | ||
| Q2 25 | 0.4% | 7.2% | ||
| Q1 25 | 1.9% | 0.1% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | 0.7% | -12.1% | ||
| Q2 24 | 3.8% | -13.0% | ||
| Q1 24 | 3.3% | -33.4% |
| Q4 25 | — | $0.05 | ||
| Q3 25 | $0.05 | $0.08 | ||
| Q2 25 | $0.10 | $0.06 | ||
| Q1 25 | $0.41 | $0.00 | ||
| Q4 24 | — | $-0.10 | ||
| Q3 24 | $0.15 | $-0.09 | ||
| Q2 24 | $0.84 | $-0.09 | ||
| Q1 24 | $0.74 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $321.0M | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $1.4B | $4.4B |
| Total Assets | $4.5B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.5B | ||
| Q3 25 | $321.0M | $4.0B | ||
| Q2 25 | $323.1M | $2.8B | ||
| Q1 25 | $261.0M | $2.5B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | $266.4M | $2.7B | ||
| Q2 24 | $225.8M | $2.6B | ||
| Q1 24 | $245.5M | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $4.4B | ||
| Q3 25 | $1.4B | $4.1B | ||
| Q2 25 | $1.4B | $3.8B | ||
| Q1 25 | $1.3B | $3.5B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | $1.4B | $3.4B | ||
| Q2 24 | $1.4B | $3.4B | ||
| Q1 24 | $1.3B | $3.4B |
| Q4 25 | — | $8.2B | ||
| Q3 25 | $4.5B | $7.6B | ||
| Q2 25 | $4.7B | $6.3B | ||
| Q1 25 | $4.5B | $5.8B | ||
| Q4 24 | — | $5.9B | ||
| Q3 24 | $4.5B | $5.8B | ||
| Q2 24 | $4.4B | $5.7B | ||
| Q1 24 | $4.5B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.4M | $417.3M |
| Free Cash FlowOCF − Capex | $66.5M | $379.8M |
| FCF MarginFCF / Revenue | 2.9% | 25.4% |
| Capex IntensityCapex / Revenue | 0.9% | 2.5% |
| Cash ConversionOCF / Net Profit | 17.12× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $13.7M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $417.3M | ||
| Q3 25 | $87.4M | $402.6M | ||
| Q2 25 | $18.3M | $263.6M | ||
| Q1 25 | $-78.8M | $44.1M | ||
| Q4 24 | — | $75.2M | ||
| Q3 24 | $101.0M | $188.4M | ||
| Q2 24 | $40.2M | $-95.6M | ||
| Q1 24 | $-35.0M | $-308.6M |
| Q4 25 | — | $379.8M | ||
| Q3 25 | $66.5M | $354.5M | ||
| Q2 25 | $-1.0M | $219.8M | ||
| Q1 25 | $-131.6M | $-12.3M | ||
| Q4 24 | — | $-17.3M | ||
| Q3 24 | $79.9M | $54.7M | ||
| Q2 24 | $22.8M | $-205.5M | ||
| Q1 24 | $-53.2M | $-465.1M |
| Q4 25 | — | 25.4% | ||
| Q3 25 | 2.9% | 25.1% | ||
| Q2 25 | -0.0% | 16.7% | ||
| Q1 25 | -6.3% | -1.1% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | 3.9% | 5.5% | ||
| Q2 24 | 1.1% | -22.1% | ||
| Q1 24 | -2.5% | -61.9% |
| Q4 25 | — | 2.5% | ||
| Q3 25 | 0.9% | 3.4% | ||
| Q2 25 | 0.8% | 3.3% | ||
| Q1 25 | 2.5% | 5.0% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | 1.0% | 13.3% | ||
| Q2 24 | 0.8% | 11.8% | ||
| Q1 24 | 0.9% | 20.8% |
| Q4 25 | — | 6.28× | ||
| Q3 25 | 17.12× | 3.22× | ||
| Q2 25 | 1.84× | 2.79× | ||
| Q1 25 | -2.02× | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.01× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | -0.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
